OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prospects of focal adhesion kinase inhibitors as a cancer therapy in preclinical and early phase study
Jiaming Gao, Jingwen Cheng, Wanyu Xie, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 6, pp. 639-651
Closed Access | Times Cited: 4
Jiaming Gao, Jingwen Cheng, Wanyu Xie, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 6, pp. 639-651
Closed Access | Times Cited: 4
Showing 4 citing articles:
Discovery of 2,4-diaminopyrimidine derivatives as potent inhibitors of FAK capable of activating the Hippo pathway for the treatment of esophageal squamous cell carcinoma
Xiao Wang, Yin-Ru Li, Ji Wu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117328-117328
Closed Access
Xiao Wang, Yin-Ru Li, Ji Wu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117328-117328
Closed Access
Clinical Importance of Focal Adhesion Kinase (FAK)-Src and Paxillin Expression in Renal Cell Carcinoma
Panagiotis Mitsos, Ioannis Anastasiou, Constantinos Constantinides, et al.
Cureus (2024)
Open Access | Times Cited: 1
Panagiotis Mitsos, Ioannis Anastasiou, Constantinos Constantinides, et al.
Cureus (2024)
Open Access | Times Cited: 1
Immunohistochemistry identifies E-cadherin, N-cadherin and focal adhesion kinase (FAK) as predictors of stage I non-small cell lung carcinoma spread through the air spaces (STAS), and the combinations as prognostic factors
Yunchang Meng, Yimin Wang, Leilei Liu, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 7, pp. 1450-1462
Open Access
Yunchang Meng, Yimin Wang, Leilei Liu, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 7, pp. 1450-1462
Open Access
Focal adhesion kinase as a new player in the biology of onco-hematological diseases: the starting evidence
Guido Capasso, Nayla Mouawad, Maria Castronuovo, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Guido Capasso, Nayla Mouawad, Maria Castronuovo, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Targeting a key FAK-tor: the therapeutic potential of combining focal adhesion kinase (FAK) inhibitors and chemotherapy for chemoresistant non-small cell lung cancer
Emma Geijerman, Francesca Terrana, Godefridus J. Peters, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 11, pp. 1103-1118
Closed Access
Emma Geijerman, Francesca Terrana, Godefridus J. Peters, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 11, pp. 1103-1118
Closed Access
